drugset / Trial / NCT06216197

Dexmedetomidine Versus Fentanyl as an Adjuvant to Bupivacaine in Saddle Block

NCT06216197 ↗

Completed 58 enrolled Zulekha Hospitals
RandomizedParallel-groupSingle-blindScreening

Summary

Dexmedetomidine is recommended over fentanyl as adjunctive medication to bupivacaine for saddle block spinal anesthesia in anal surgeries and procedures.

Timeline

Start
2021-04-03
Primary completion
2022-12-04
Completion
2022-12-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 10 ug Intrathecal
Subject Fentanyl Other / unclassified 25 ug Intrathecal
Background Bupivacaine Other / unclassified 2.5 ml Intrathecal

Indications

No indication recorded.